Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Gn-RH antagonist possible response, after Gn-RH Agonist failure in a man with metastatic prostate cancer / B. Rocco, M. Ferrari, E. Scardino, D.V. Matei, F. Verweij, R. Varela, O. De Cobelli. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005 Jan), pp. 577-578.
Gn-RH antagonist possible response, after Gn-RH Agonist failure in a man with metastatic prostate cancer
B. Rocco;O. De Cobelli
2005
Abstract
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
| File | Dimensione | Formato | |
|---|---|---|---|
|
577.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
34.72 kB
Formato
Adobe PDF
|
34.72 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
